Begin main content

Reports

We found 5474 result(s)

risankizumab (Skyrizi)

Last Updated: December 13, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: risankizumab
Indications: Psoriasis, moderate to severe plaque

  • Brand Name: Skyrizi
  • Manufacturer: AbbVie Corporation
  • Project Number: SR0583-000
  • Project Status: Active
  • Submission Type: New

efinaconazole (Jublia)

Last Updated: April 18, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: efinaconazole
Indications: Onychomycosis

  • Brand Name: Jublia
  • Manufacturer: Bausch Health, Canada Inc.
  • Project Number: SR0577-000
  • Project Status: Active
  • Submission Type: New

crisaborole (Eucrisa)

Last Updated: April 18, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: crisaborole
Indications: atopic dermatitis

  • Brand Name: Eucrisa
  • Manufacturer: Pfizer Canada Inc.
  • Project Number: SR0570-000
  • Project Status: Complete
  • Submission Type: New

cerliponase alfa (Brineura)

Last Updated: December 21, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: cerliponase alfa
Indications: Neuronal Ceroid Lipofuscinosis Type 2

  • Brand Name: Brineura
  • Manufacturer: Biomarin Pharmaceutical (Canada) Inc.
  • Project Number: SR0574-000
  • Project Status: Active
  • Submission Type: New

buprenorphine (Sublocade)

Last Updated: December 21, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: buprenorphine
Indications: Opioid use disorder, treatment

  • Brand Name: Sublocade
  • Manufacturer: Indivior Canada Ltd.
  • Project Number: SR0579-000
  • Project Status: Active
  • Submission Type: New

Nusinersen (Spinraza)

Last Updated: April 5, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: Nusinersen
Indications: Spinal Muscular Atrophy

  • Brand Name: Spinraza
  • Manufacturer: Biogen Canada Inc.
  • Project Number: SR0576-000
  • Project Status: Complete
  • Submission Type: Resubmission

tofacitinib (Xeljanz)

Last Updated: April 4, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: tofacitinib
Indications: Ulcerative colitis

  • Brand Name: Xeljanz
  • Manufacturer: Pfizer Canada Inc.
  • Project Number: SR0572-000
  • Project Status: Complete
  • Submission Type: NewIndication

edaravone (Radicava)

Last Updated: April 17, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: edaravone
Indications: amyotrophic lateral sclerosis

  • Brand Name: Radicava
  • Manufacturer: Mitsubishi Tanabe Pharma Corporation
  • Project Number: SR0573-000
  • Project Status: Active
  • Submission Type: New